Lipoprotein(a) and apolipoprotein B as risk factors in coronary heart disease and acute myocardial infarction development

by G. G. Arabidze
Published 2005-02-01

Ebrantil pri gipertonicheskom krize v statsionare na fone dlitel'noy gipotenzivnoy terapii

by G. G Arabidze, O. V Polyakova
Published 2015-12-01

Predictive value of copeptin in the development of severe heart failure in patients with acute coronary syndrome without ST-segment elevation

by A. V Zhukova, G. G Arabidze
Published 2018-03-01

The role of increased lipoprotein (a) and apolipoprotein B-100 levels, and their link to cholesterol and triglyceride concentration in coronary heart disease patients

by G. G. Arabidze, E. O. Skryabina, I. G. Inaneishvili, O. I. Afanasyeva
Published 2006-10-01

Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure

by E. V. Kovalenko, M. V. Lozhkina, G. G. Arabidze, V. G. Kryakushkin
Published 2021-02-01

Clinical case of rheumatoid arthritis with antiphospholipid antibody syndrome

by G. G Arabidze, A. V Shapchenko, O. V Muslimova, O. Yu Larina, A. M Sorokoletov
Published 2015-09-01

Lipoprotein (a) and apolipoprotein BD100 in coronary heart disease pathogenesis

by K. I. Tebloev, G. G. Arabidze, O. V. Polyakova, O. I. Afanasyeva, M. I. Afanasyeva, E. O. Skryabina
Published 2005-10-01